News

A new platform has been designed to deliver a universal influenza vaccine candidate to immune cells and the results in mice are suggesting that the immunization effectively protects against multiple flu strains.

Mycobacteria are known to cause tuberculosis and leprosy in humans and it has now been identified that they can bind to red blood cells and multiply extracellularly.

University of Liverpool scientists have taken a significant step towards unlocking the medical potential of a new class of potent antibiotic capable of killing "superbugs" including MRSA without detectable resistance.

Scientists have shown that responses to the Pfizer-BioNTech BNT162b2 mRNA vaccine differ significantly in individuals based on whether or not they were previously infected with SARS-CoV-2.

New research suggests that the drug sargramostim, currently being trialed in Alzheimer’s patients, may also improve cognitive function in people with Down syndrome.

Research provides insights into the pathways that increase or decrease the bone marrow’s output of immune cells that can help or harm the heart.

A COVID-19 sensor could revolutionize virus testing by adding accuracy and speed to a process that frustrated many during the pandemic.

A study in killifishes, an animal model for aging, has shown that older fish have different types and a lower diversity of circulating antibodies.

A survey has been conducted to uncover how the public feels about the distribution of vaccines.

UConn Health researchers how deleting a protein could prevent fat-filled macrophages narrowing blood vessels and causing heart disease.